Select a community
Fibromyalgia And Chronic Fatigue Syndrome
Find out more about the PatientsLikeMe
Fibromyalgia And Chronic Fatigue Syndrome Community
Home > Community Treatment Reports > Glatiramer acetate Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Glatiramer acetate Treatment Report

Brand Names: Copaxone

What is Glatiramer acetate? Glatiramer acetate combines four amino acids including L-alanine, L-glutamic acid, L-lysine and L-tyrosine. It is used for Relapsing-Remitting Multiple Sclerosis (RRMS) to reduce the frequency and severity of relapses. It is administered as a subcutaneous injection.

See more information, including instructions, precautions, side effects, and interactions.


Reasons taken

2 patients in the community are taking or have taken Glatiramer acetate.

Reason # Patients Percentage of patients
Multiple Sclerosis (MS) 1 50%

Dosages

Based on the patients currently taking Glatiramer acetate.

  20 mg daily
  1 Number of Patients: 1  

Duration

How long current patients have been taking Glatiramer acetate or how long patients were taking Glatiramer acetate before stopping.

Currently Taking Glatiramer acetate

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0
1

Stopped Taking Glatiramer acetate

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
0
0
0
0
Why Patients Stopped Taking Glatiramer acetate (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 1 100% Side effects too severe: 100%

Report created on November 07, 2009.